Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial
Zhu, XF; Cao, YS; Liu, WY; Ju, XP; Zhao, XZ; Jiang, LG; Ye, YS; Jin, G; Zhang, HJ
Zhang, HJ (corresponding author), Naval Med Univ, Changhai Hosp, Dept Radiat Oncol, Shanghai 200433, Peoples R China.; Jin, G (corresponding author), Naval Med Univ, Changhai Hosp, Dept Hepatobiliary & Pancreat Surg, Shanghai 200433, Peoples R China.
LANCET ONCOLOGY, 2021; 22 (8): 1093